Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
April 18, 2022 at 06:02 am EDT
Share
Zhejiang Tailin BioEngineering Co.,Ltd reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 253.64 million compared to CNY 175.5 million a year ago. Revenue was CNY 283.25 million compared to CNY 200.24 million a year ago. Net income was CNY 63.53 million compared to CNY 48.39 million a year ago. Basic earnings per share from continuing operations was CNY 0.7625 compared to CNY 0.5938 a year ago. Diluted earnings per share from continuing operations was CNY 0.7625 compared to CNY 0.5938 a year ago.
Zhejiang Tailin Bioengineering Co., Ltd. is a China-based company mainly engaged in pharmaceutical equipment business. The Company's main business is the research, development, manufacturing and sales of microbial detection and control technology system products, organic substance analysis instruments and other pharmaceutical equipment. Specific products include various consumables, instruments and equipment, which can be used alone or in combination for the production and quality of sterile drugs. The application areas that can be expanded include medical and health, food safety, disease prevention and control, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. The Company distributes its products within domestic market and to overseas markets.
ZHEJIANG TAILIN BIOENGINEERING CO.,LTD 
